Neurodevelopmental outcomes after congenital heart surgery and strategies for improvement

Sarah Tabbutt1, J William Gaynor, Jane W Newburger

  • 1University of California San Francisco Benioff Children's Hospital, San Francisco, California, USA. tabbutts@peds.ucsf.edu

Insights

Neonatal heart surgery for complex congenital heart lesions may impact neurodevelopmental outcomes. Research indicates patient and socioeconomic factors are primary risks, with few modifiable variables influencing infant brain development.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Congenital Heart Disease Research

Background:

  • Neonatal and infant heart surgery for complex congenital heart lesions is a critical intervention.
  • Pre-existing brain immaturity is often observed in newborns with these conditions.

Purpose of the Study:

  • To review neurodevelopmental and neuropsychologic outcomes after neonatal and infant heart surgery for complex congenital heart lesions.
  • To analyze recent data on perioperative magnetic resonance imaging (MRI) and randomized clinical trials (RCTs) concerning perioperative variables.

Main Methods:

  • Review of recent reports on perioperative MRI.
  • Analysis of recent randomized clinical trials addressing perioperative variables.
  • Exploration of robust analyses from clinical, cross-sectional, and prospective trials.

Main Results:

  • Advancements in MRI confirm newborns with complex congenital heart lesions often have brain immaturity.
  • RCTs found no significant difference in 1-year outcomes between regional cerebral perfusion and deep hypothermic circulatory arrest.
  • No significant differences in outcomes were found for different shunt types in the Norwood procedure or for cardiopulmonary bypass methods in arterial switch operations.

Conclusions:

  • Most identified risk factors for worsened neurodevelopmental outcomes are patient-related or socioeconomic.
  • Few risk factors influencing neurodevelopmental outcomes are potentially modifiable.
  • Further research is needed to identify and address modifiable risk factors.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...